AQSE Rule 4.14
Ananda’s mission is to become a leading UK grower and provider of high quality, consistent, carbon zero, medical cannabis for the UK and international markets.
It will achieve this via;
- the cultivation of medical cannabis at its dedicated UK facility, utilising proven low capital and low operating cost growing methods; as well as by cultivating its unique strains which are being developed in its strain stabilisation breeding programme. It will also process, formulate and manufacture medical cannabis to create both flower and oil products.
- the supply of UK manufactured cannabis oil medicines to the UK market, as specials in the first instance, using the IP owned by MRX.
Shareholders’ attention is drawn to the risk factors set out in Part II of the Company’s Admission Document dated 21 June 2018 and available on this website at the following link: Admission Document.